{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:16:58Z","timestamp":1783138618083,"version":"3.54.6"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7768-26","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:10:15Z","timestamp":1783116615000},"source":"Crossref","is-referenced-by-count":0,"title":["Inflammasomes in Intestinal Inflammation: Guardians of Mucosal Homeostasis, Amplifiers of Disease, and Targets for Intervention"],"prefix":"10.2169","author":[{"given":"Hiroshi","family":"Nakase","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shimomori","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurumi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1\u03b2. Mol Cell 10: 417-426, 2002.","DOI":"10.1016\/S1097-2765(02)00599-3"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Schroder K, Tschopp J. The inflammasomes. Cell 140: 821-832, 2010.","DOI":"10.1016\/j.cell.2010.01.040"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Rathinam VAK, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell 165: 792-800, 2016.","DOI":"10.1016\/j.cell.2016.03.046"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Barnett KC, Li S, Liang K, Ting JP-Y. A 360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell. 186: 2288-2312, 2023.","DOI":"10.1016\/j.cell.2023.04.025"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti T-D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32: 379-391, 2010.","DOI":"10.1016\/j.immuni.2010.03.003"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Dupaul-Chicoine J, Yeretssian G, Doiron K, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32: 367-378, 2010.","DOI":"10.1016\/j.immuni.2010.02.012"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757, 2011.","DOI":"10.1016\/j.cell.2011.04.022"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Wlodarska M, Thaiss CA, Nowarski R, et al. NLRP6 inflammasome orchestrates the colonic host\u2013microbial interface by regulating goblet cell mucus secretion.. Cell 156: 1045-1059, 2014.","DOI":"10.1016\/j.cell.2014.01.026"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Levy M, Thaiss CA, Zeevi D, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163: 1428-1443, 2015.","DOI":"10.1016\/j.cell.2015.10.048"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lemire P, Robertson SJ, Maughan H, et al. The NLR protein NLRP6 does not impact gut microbiota composition. Cell Rep 21: 3653-3661, 2017.","DOI":"10.1016\/j.celrep.2017.12.026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Volk JK, Nystr\u00f6m EEL, van der, Post S, et al. The Nlrp6 inflammasome is not required for baseline colonic inner mucus layer formation or function. J Exp Med 216: 2602-2618, 2019.","DOI":"10.1084\/jem.20190679"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Nowarski R, Jackson R, Gagliani N, et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell 163: 1444-1456, 2015.","DOI":"10.1016\/j.cell.2015.10.072"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Harrison OJ, Srinivasan N, Pott J, et al. Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3<sup>+<\/sup> Treg cell function in the intestine. Mucosal Immunol 8: 1226-1236, 2015.","DOI":"10.1038\/mi.2015.13"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hu S, Peng L, Kwak Y-T, et al. The DNA sensor AIM2 maintains intestinal homeostasis via regulation of epithelial antimicrobial host defense. Cell Rep 13: 1922-1936, 2015.","DOI":"10.1016\/j.celrep.2015.10.040"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ratsimandresy RA, Indramohan M, Dorfleutner A, Stehlik C. The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18\/IL-22\/STAT3 pathway. Cell Mol Immunol 14: 127-142, 2017.","DOI":"10.1038\/cmi.2016.35"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rauch I, Deets KA, Ji DX, et al. NAIP\u2013NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8. Immunity 46: 649-659, 2017.","DOI":"10.1016\/j.immuni.2017.03.016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Knodler LA, Crowley SM, Sham HP, et al. Noncanonical inflammasome activation of caspase-4\/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 16: 249-256, 2014.","DOI":"10.1016\/j.chom.2014.07.002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Demon D, Kuchmiy A, Fossoul A, Zhu Q, Kanneganti TD, Lamkanfi M. Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis. Mucosal Immunol 7: 1480-1491, 2014.","DOI":"10.1038\/mi.2014.36"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bulek K, Zhao J, Liao Y, et al. Epithelial-derived gasdermin D mediates nonlytic IL-1\u03b2 release during experimental colitis. J Clin Invest 130: 4218-4234, 2020.","DOI":"10.1172\/JCI138103"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Rana N, Privitera G, Kondolf HC, et al. GSDMB is increased in IBD and regulates epithelial restitution\/repair independent of pyroptosis. Cell 185: 283-298.e17, 2022.","DOI":"10.1016\/j.cell.2021.12.024"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Villani A-C, Lemire M, Fortin G, et al. Common variants in the NLRP3 region contribute to Crohn&apos;s disease susceptibility. Nat Genet 41: 71-76, 2009.","DOI":"10.1038\/ng.285"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zmora N, Levy M, Pevsner-Fishcer M, Elinav E. Inflammasomes and intestinal inflammation. Mucosal Immunol 10: 865-883, 2017.","DOI":"10.1038\/mi.2017.19"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Coll RC, Robertson AAB, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21: 248-255, 2015.","DOI":"10.1038\/nm.3806"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Perera AP, Fernando R, Shinde T, et al. MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. Sci Rep 8: 8618, 2018.","DOI":"10.1038\/s41598-018-26775-w"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17: 914-921, 2016.","DOI":"10.1038\/ni.3457"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I. The pyrin inflammasome in health and disease. Front Immunol 10: 1745, 2019.","DOI":"10.3389\/fimmu.2019.01745"},{"key":"27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1159\/000502640","volume":"101","author":"D Saito","year":"2020","unstructured":"27. Saito D, Hibi N, Ozaki R, et al. MEFV gene-related enterocolitis account for some cases diagnosed as inflammatory bowel disease unclassified. Digestion 101: 785-793, 2020.","journal-title":"Digestion","ISSN":"https:\/\/id.crossref.org\/issn\/0012-2823","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nakase H, Wagatsuma K, Kobayashi T, et al. Involvement of Mediterranean fever gene mutations in colchicine-responsive enterocolitis: a retrospective cohort study. EBiomedicine 110: 105454, 2024.","DOI":"10.2139\/ssrn.4819257"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7768-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:28:24Z","timestamp":1783135704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7768-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7768-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7768-26"}}